Consonance Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-564,375	Closed	-$10M	–	29
2015 Q1	$10M	Buy	564,375 +56,641	+11%	+$1.01M	0.91%	21
2014 Q4	$9.34M	Buy	507,734 +5,000	+1%	+$92K	1.2%	18
2014 Q3	$12.2M	Buy	+502,734	New	+$12.2M	1.67%	21